Regeneron Pharmaceuticals(REGN-Q)NASDAQ
Today's Change
Real-Time Last Update
After Hours Change
After Hours Last Update
Volume
Current Target Price
High Target Price
Mean Target Price
Low Target Price
Median Target Price
Earnings Estimates
| Current Qtr09/2024 | Next Qtr12/2024 | Fiscal Yr12/2024 | Fiscal Yr12/2025 | |
|---|---|---|---|---|
| Average Estimate | 10.14 | 9.73 | 37.66 | 40.02 |
| Number of Estimates | 10 | 9 | 11 | 10 |
| High Estimate | 11.73 | 11.67 | 40.90 | 45.34 |
| Low Estimate | 9.28 | 7.63 | 35.41 | 33.02 |
| Prior Year | 10.17 | 10.18 | 37.66 | 37.66 |
| Growth Rate Est. (year over year) | -0.29% | -4.42% | unch | +6.27% |
Earnings History - Surprises*
| Qtr Ending06/2024 | Qtr Ending03/2024 | Qtr Ending12/2023 | Qtr Ending09/2023 | |
|---|---|---|---|---|
| Reported | $10.10 | $7.97 | $10.18 | $10.17 |
| Estimate | $8.93 | $8.46 | $9.10 | $9.39 |
| Difference | +1.17 | -0.49 | +1.08 | +0.78 |
| Surprise | +13.10% | -5.79% | +11.87% | +8.31% |
* Earnings are based on GAAP income from continuing operations.
Average Analyst Ratings
Rating
Strong Buy
Moderate Buy
Hold
Moderate Sell
Strong Sell
# of Analysts
4.46
3 Mths Ago26
4.52
2 Mths Ago25
4.52
1 Mth Ago25
4.44
Current25
Ratings Values:
Strong Buy5
Moderate Buy4
Hold3
Moderate Sell2
Strong Sell1
Ratings Breakdown
| 3 Mths Ago | 2 Mths Ago | 1 Mth Ago | Current | |
|---|---|---|---|---|
| # of Analysts: | 26 | 25 | 25 | 25 |
19 1 | 19 1 | 19 1 | 18 1 | |
| Holds | 5 | 4 | 4 | 5 |
1 | 1 | 1 | 1 |
Key:
Strong Buy
Moderate Buy
Hold
Moderate Sell
Strong Sell